Burden of disease and barriers to the diagnosis and treatment of group a beta-hemolytic streptococcal pharyngitis for the prevention of rheumatic heart disease in Dar Es Salaam, Tanzania.

dc.contributor.author	Fataki, Maulidi R.
dc.date.accessioned	2022-08-24T12:05:02Z
dc.date.available	2022-08-24T12:05:02Z
dc.date.issued	2010
dc.description.abstract	To understand patient and clinician attitudes toward Streptococ- cus pharyngitis and rheumatic heart disease prevention in Tanzania, data from 3 sources were obtained: a survey of 119 clinicians, outpatient rapid test screening, and interviews with 17 rheumatic heart disease patients. Patients do not seek care for sore throat. Clinicians stated that identifying and treating Streptococcus pharyngitis is not prioritized	en_US
dc.identifier.citation	Bergmark, R., Bergmark, B., Blander, J., Fataki, M. and Janabi, M., 2010. Burden of disease and barriers to the diagnosis and treatment of group a beta-hemolytic streptococcal pharyngitis for the prevention of rheumatic heart disease in Dar Es Salaam, Tanzania. The Pediatric infectious disease journal, 29(12), pp.1135-1137.	en_US
dc.identifier.other	DOI: 10.1097/INF.0b013e3181edf475
dc.identifier.uri	http://hdl.handle.net/123456789/1035
dc.language.iso	en	en_US
dc.publisher	The Pediatric infectious disease journal	en_US
dc.subject	Rheumatic heart disease	en_US
dc.subject	Rheumatic fever	en_US
dc.subject	Streptococcus	en_US
dc.title	Burden of disease and barriers to the diagnosis and treatment of group a beta-hemolytic streptococcal pharyngitis for the prevention of rheumatic heart disease in Dar Es Salaam, Tanzania.	en_US
dc.type	Article	en_US